You are here: Home ยป Archives for Conference Calls/ Webcasts

Axi startet nach erfolgreicher Bloomberg-Kampagne die neue Webinar-Reihe „Axi Select“

SYDNEY, March 27, 2026 (GLOBE NEWSWIRE) — Der weltweit tätige Online-Broker Axi hat die Einführung einer neuen Webinar-Reihe im Rahmen seines „Axi Select“-Programms angekündigt und baut damit seine Bildungsinitiative für Trader nach dem erfolgreichen Abschluss seiner jüngsten Bloomberg-Kampagne weiter aus. Das erste Webinar ist für April 2026 geplant und wird Teil einer fortlaufenden Reihe sein, die der globalen Trading-Community von Axi von Experten geleitete Markteinblicke und praktische Trading-Schulungen bieten soll.

Die neue Webinar-Reihe stellt die nächste Phase des Engagements von Axi dar, die Weiterbildung von Tradern durch leicht zugängliche, professionelle Schulungen zu fördern. Aufbauend auf der starken Resonanz, die während der Bloomberg-Kampagne erreicht wurde, zielt die Initiative darauf ab, Tradern ein tieferes Marktverständnis, strukturierte Lernmöglichkeiten und direkten Zugang zu erfahrenen Marktexperten zu bieten.

Greg Rubin, Head of Axi Select bei Axi:

„Die Bloomberg-Kampagne machte deutlich, dass die Nachfrage nach glaubwürdigen, von Experten geleiteten Schulungen wächst, die Tradern helfen, die schnelllebigen Märkte von heute besser zu verstehen. Mit dem Start der Axi Select-Webinarreihe können wir diesen Dialog fortsetzen, indem wir Tradern direkten Zugang zu Einblicken, Analysen und praktischem Wissen bieten, das darauf ausgerichtet ist, ihre langfristige Entwicklung im Trading zu fördern.“

Die Eröffnungsveranstaltung wird von Cassandra Ng moderiert, einer Finanzmarktanalystin, Dozentin und Trading-Spezialistin mit langjähriger Erfahrung in der Kommentierung von Marktentwicklungen und der Vermittlung von Trading-Kenntnissen an ein internationales Publikum. Im Mittelpunkt der Veranstaltung stehen Marktprognosen, Handelsstrategien und Grundsätze des Risikomanagements, die Tradern helfen sollen, sich in einem sich wandelnden Marktumfeld sicherer zu bewegen.

Cassandra meinte dazu:

„Weiterbildung ist für Trader, die an den Märkten Beständigkeit und Disziplin entwickeln möchten, unverzichtbar. Diese Webinar-Reihe soll komplexe Marktbewegungen verständlich machen und praktische Erkenntnisse liefern, die Trader in ihren eigenen Strategien umsetzen können.“

Über die Referentin

Cassandra Ng ist Traderin bei einer Prop-Firma und Marktanalystin bei einem preisgekrönten Research-Unternehmen – dort fließen ihre Forschungsergebnisse täglich in die Entscheidungen Tausender Trader ein. Ihre Spezialgebiete sind die Elliott-Wellen-Theorie und Fibonacci-Zahlen – damit prognostiziert sie, wohin sich die Märkte entwickeln werden. Nach jahrelanger Erfahrung in der Zusammenarbeit mit Privatanlegern und professionellen Tradern ist sie darauf spezialisiert, komplexe Finanzkonzepte durch Webinare, Workshops und Marktanalysen in praktisches Handelswissen umzusetzen.

Die Webinar-Reihe ist Teil der übergeordneten Mission von Axi, Trader durch Weiterbildung, Technologie und strukturierte Entwicklungsmöglichkeiten zu unterstützen. Durch den Übergang von reinen Informationsangeboten zu interaktiven Lernerfahrungen unterstreicht Axi weiterhin sein Bestreben, einen echten Mehrwert zu bieten, der über den reinen Zugang zum Handel hinausgeht.

Die Anmeldung ist jetzt möglich, und interessierte Trader können sich unter folgender Adresse einen Platz sichern:

https://axicorp.zoom.us/webinar/register/WN_h2n3EqLTT-qQww5BZtrx2g

Über Axi

Axi ist ein globaler Online-Broker, der Zugang zum Handel mit Devisen, Aktien, Indizes, Rohstoffen und digitalen Vermögenswerten ermöglicht. Mit Initiativen wie Axi Select unterstützt Axi Trader weltweit durch Schulungen, Technologie und professionelle Trading-Tools.

Medienkontakt: [email protected]

Weitere Informationen zum Axi-Select-Programm: https://www.axi.com/int/funded-trader-program

Das Axi Select-Programm ist ausschließlich Kundinnen und Kunden von AxiTrader LLC vorbehalten. CFDs bergen ein hohes Verlustrisiko für die Anlegerinnen und Anleger. Dieser Inhalt ist in Ihrer Region möglicherweise nicht verfügbar. Weitere Informationen finden Sie in unseren allgemeinen Geschäftsbedingungen. Es gelten die üblichen Handelsgebühren sowie Mindestanforderungen für Einzahlungen.


GLOBENEWSWIRE (Distribution ID 1001172530)

Suite au succès de sa campagne Bloomberg, Axi lance une nouvelle série de webinaires « Axi Select »

SYDNEY, 27 mars 2026 (GLOBE NEWSWIRE) — Axi, fournisseur mondial de services de trading en ligne, a annoncé le lancement d’une nouvelle série de webinaires éducatifs dans le cadre de son programme Axi Select, élargissant ainsi son initiative de formation des traders suite au succès de sa récente campagne Bloomberg. Le premier webinaire est prévu pour avril 2026 et sʼinscrira dans le cadre dʼune série continue destinée à offrir à la communauté mondiale de traders dʼAxi des analyses de marché réalisées par des experts ainsi qu’une formation concrète au trading.

Cette nouvelle série de webinaires marque un cap dans lʼengagement dʼAxi à accompagner le développement des traders grâce à une formation accessible et de niveau professionnel. S’appuyant sur le fort engagement du public suscité lors de la campagne Bloomberg, cette initiative vise à permettre aux traders d’approfondir leur compréhension du marché, à leur proposer des opportunités d’apprentissage structurées et à les mettre en relation directe avec des professionnels expérimentés du marché.

Greg Rubin, responsable d’Axi Select chez Axi, a déclaré :

« La campagne Bloomberg a mis en évidence une demande croissante en matière de formation fiable, dispensée par des experts, permettant aux traders de mieux comprendre les marchés actuels, caractérisés par une évolution fulgurante. En mettant en place la série de webinaires Axi Select, nous souhaitons poursuivre ce dialogue avec les traders en leur donnant un accès direct à des informations, des analyses et des conseils pratiques destinés à les accompagner dans leur développement à long terme en matière de trading. »

La première session sera animée par Cassandra Ng, analyste des marchés financiers, formatrice et spécialiste du trading, forte dʼune vaste expérience dans la présentation d’analyses de marché et la formation au trading auprès d’un public international. Cette session portera sur les perspectives du marché, les stratégies de trading et les concepts de gestion des risques, dans le but de permettre aux traders de s’adapter aux conditions fluctuantes du marché avec davantage d’assurance.

Cassandra a ajouté :

« La formation est indispensable pour les traders souhaitant acquérir une approche cohérente et disciplinée sur les marchés. Cette série de webinaires a pour objectif de démêler les mouvements complexes du marché et de fournir des informations concrètes que les traders peuvent intégrer à leurs propres stratégies. »

À propos de la présentatrice

Cassandra Ng est trader pour le compte de la société et analyste de marché au sein d’un cabinet d’études réputé, où ses analyses éclairent chaque jour les décisions de milliers de traders. Elle est spécialisée dans la théorie des vagues d’Elliott couplée aux ratios de Fibonacci, qu’elle utilise pour prévoir l’évolution des marchés. Forte de nombreuses années d’expérience auprès de traders particuliers et professionnels, elle s’est spécialisée dans la vulgarisation de concepts financiers complexes en connaissances pratiques de trading, par le biais de webinaires, d’ateliers et d’analyses de marché.

Cette série de webinaires s’inscrit dans le prolongement de la mission globale dʼAxi, consistant à donner aux traders les moyens d’agir grâce à la formation, à la technologie et à des opportunités de développement structurées. En évoluant de lʼengagement via la diffusion vers des expériences d’apprentissage interactives, Axi continue de mettre davantage l’accent sur la création dʼune valeur ajoutée significative, au-delà du simple accès aux marchés.

Les inscriptions sont désormais ouvertes, et les traders peuvent réserver leur place en se rendant à l’adresse suivante :

https://axicorp.zoom.us/webinar/register/WN_h2n3EqLTT-qQww5BZtrx2g

À propos d’Axi

Plateforme de trading en ligne internationale, Axi offre un accès au Forex, aux actions, aux indices, aux matières premières et aux actifs numériques. Grâce à des initiatives telles qu’Axi Select, Axi accompagne les traders du monde entier en leur proposant des formations, des technologies et des outils de trading professionnels.

Contact presse : [email protected]

Pour en savoir plus sur le programme Axi Select, rendez-vous sur https://www.axi.com/int/funded-trader-program

Le programme Axi Select est exclusivement réservé aux clients d’AxiTrader LLC. Les CFD comportent un risque élevé de perte en capital. Ce contenu peut ne pas être disponible dans votre région. Pour obtenir de plus amples informations, veuillez consulter nos Conditions générales. Hors frais de trading standard et de dépôt minimum.


GLOBENEWSWIRE (Distribution ID 1001172530)

Axi Lança Nova Série de Webinars Axi Select Após Campanha de Sucesso na Bloomberg

SYDNEY, March 27, 2026 (GLOBE NEWSWIRE) — A Axi, provedora global de negociação online, anunciou o lançamento de uma nova série de webinars educacionais no seu programa Axi Select, expandindo sua iniciativa de educação para traders após o sucesso da sua recente campanha na Bloomberg. O primeiro webinar com início em abril de 2026 será uma série contínua, criada para oferecer insights do mercado e educação prática em negociação de experts para a comunidade global de traders da Axi.

A nova série de webinars é a próxima fase do compromisso da Axi em apoiar o desenvolvimento dos traders por meio de uma educação acessível e de nível profissional. Com base na forte interação do público durante a campanha da Bloomberg, a iniciativa visa proporcionar aos traders uma compreensão mais aprofundada do mercado, oportunidades de aprendizado estruturado e acesso direto aos profissionais experientes do setor.

Greg Rubin, Diretor da Axi Select na Axi, disse:

“A campanha da Bloomberg destacou uma demanda crescente por uma educação confiável e conduzida por experts, que ajude os traders a compreender melhor os mercados dinâmicos atuais. O lançamento da série de webinars Axi Select possibilita a continuidade dessa conversa e proporciona aos traders acesso direto a insights, análises e conhecimentos práticos, elaborados para apoiar o desenvolvimento das suas atividades de trading a longo prazo,”

A primeira sessão será conduzida pela analista de mercados financeiros, educadora e especialista em trading, Cassandra Ng, que tem vasta experiência na apresentação de análises de mercado e na oferta de educação em trading para uma audiência global. A sessão se concentrará em perspectivas do mercado, estruturas operacionais e princípios de gestão de riscos, com o objetivo de auxiliar os traders a navegar pelas condições do mercado em constante evolução com maior confiança.

Cassandra comentou:

“A educação é essencial para os traders que querem construir consistência e disciplina nos mercados. Esta série de webinars foi criada para simplificar movimentos complexos do mercado e fornecer insights práticos que os traders possam aplicar nas suas próprias estratégias.”

Sobre a Apresentadora

Cassandra Ng é trader em uma mesa proprietária e analista de mercado em uma empresa de pesquisa premiada onde suas análises fundamentam as decisões de milhares de traders todos os dias. Ela é expert em Ondas de Elliott e em Fibonacci, ferramentas que ela utiliza para prever a direção dos mercados. Com anos de experiência trabalhando com traders de varejo e profissionais, é especialista em traduzir conceitos financeiros complexos em conhecimento prático de trading em webinars, workshops e análises de mercado.

A série de webinars expande a ampla missão da Axi de capacitar traders por meio de educação, tecnologia e oportunidades de desenvolvimento estruturado. Ao passar de um engajamento baseado em transmissão para experiências de aprendizado interativas, a Axi continua a aprofundar seu foco em uma oferta de valor significativo, além do simples acesso à negociação.

Os traders podem garantir sua vaga se inscrevendo em:

https://axicorp.zoom.us/webinar/register/WN_h2n3EqLTT-qQww5BZtrx2g

Sobre a Axi

A Axi é uma marca global de negociação online que oferece acesso a Forex, ações, índices, commodities e ativos digitais. Por meio de iniciativas como o Axi Select, a Axi apoia traders em todo o mundo com educação, tecnologia e ferramentas profissionais de negociação.

Contato da Mídia: [email protected]

Para informação completa sobre o programa Axi Select, visite: https://www.axi.com/int/funded-trader-program

O programa Axi Select está disponível somente para clientes da AxiTrader LLC. Os CFDs envolvem alto risco de perda de investimento. Este conteúdo pode não estar disponível na sua região. Para mais informações, consulte nossos Termos de Serviço. Taxas de negociação padrão e depósito mínimo são implementadas.


GLOBENEWSWIRE (Distribution ID 1001172530)

Axi Launches New Axi Select Webinar Series Following Successful Bloomberg Campaign

SYDNEY, March 27, 2026 (GLOBE NEWSWIRE) — Global online trading provider Axi has announced the launch of a new educational webinar series under its Axi Select programme, expanding its trader education initiative following the successful completion of its recent Bloomberg campaign. The first webinar is scheduled to take place in April 2026 and will form part of an ongoing series designed to deliver expert-led market insights and practical trading education to Axi’s global trading community.

The new webinar series represents the next phase of Axi’s commitment to supporting trader development through accessible, professional-grade education. Building on strong audience engagement generated during the Bloomberg campaign, the initiative aims to provide traders with deeper market understanding, structured learning opportunities, and direct access to experienced market professionals.

Greg Rubin, Head of Axi Select at Axi, said:

“The Bloomberg campaign highlighted a growing demand for credible, expert-led education that helps traders better understand today’s fast-moving markets. Launching the Axi Select webinar series allows us to continue that conversation by giving traders direct access to insights, analysis, and practical knowledge designed to support long-term trading development.”

The inaugural session will be hosted by Cassandra Ng, a financial markets analyst, educator, and trading specialist with extensive experience delivering market commentary and trading education to global audiences. The session will focus on market outlooks, trading frameworks, and risk management principles aimed at helping traders navigate evolving market conditions with greater confidence.

Cassandra commented:

“Education is essential for traders looking to build consistency and discipline in the markets. This webinar series is designed to simplify complex market movements and provide actionable insights that traders can apply within their own strategies.”

About the Presenter

Cassandra Ng is a prop firm trader and market analyst at an award-winning research firm – where her research powers the decisions of thousands of traders every day. Her speciality is in Elliott wave and Fibonacci – which she uses to forecast where the markets are heading. With years of experience working with retail and professional traders, her speciality is in translating complex financial concepts into practical trading knowledge through webinars, workshops, and market analysis.

The webinar series extends Axi’s broader mission to empower traders through education, technology, and structured development opportunities. By moving from broadcast engagement into interactive learning experiences, Axi continues to strengthen its focus on providing meaningful value beyond trading access alone.

Registration is now open, and traders can secure their place by visiting:

https://axicorp.zoom.us/webinar/register/WN_h2n3EqLTT-qQww5BZtrx2g

About Axi

Axi is a global online trading brand offering access to forex, shares, indices, commodities, and digital assets. Through initiatives such as Axi Select, Axi supports traders worldwide with education, technology, and professional trading tools.

Media Contact: [email protected]

For full details on the Axi Select program, visit: https://www.axi.com/int/funded-trader-program

The Axi Select program is only available to clients of AxiTrader LLC. CFDs carry a high risk of investment loss. This content may not be available in your region. For more information, refer to our Terms of Service. Standard trading fees and minimum deposit apply.


GLOBENEWSWIRE (Distribution ID 1001172205)

Zoom to Release Financial Results for the Fourth Quarter and Full Fiscal Year 2026

SAN JOSE, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the fourth quarter and full fiscal year 2026 on Wednesday, February 25, 2026, after the market closes.

A live Zoom Webinar of the event can be accessed at 2:00 pm PT / 5:00 pm ET through Zoom’s investor relations website at https://investors.zoom.com. A replay will be available approximately two hours after the conclusion of the live event.

About Zoom
Zoom (NASDAQ:ZM) provides the AI–first, open work platform built for human connection and purposefully designed to move conversations to completion. From entrepreneurs to global enterprises, customers choose Zoom to seamlessly collaborate, communicate, and drive outcomes across meetings, chat, phone, contact center, events, and more — all with the built–in assistance of Zoom AI Companion. Founded in 2011, Zoom is headquartered in San Jose, CA. For more information, visit zoom.com.

Public Relations
Karen Modlin
Head of Corporate Communications, Zoom
[email protected]

Investor Relations
Charles Eveslage
Head of Investor Relations, Zoom
[email protected]


GLOBENEWSWIRE (Distribution ID 9645546)

Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question–and–answer session.

To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.

A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I–IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts

Tracy Krumme (Investors) – 984–385–6707, [email protected]

Sue Zaranek (Media) – 919–943–5422, [email protected]

Kate Dillon (Media) – 646–818–9115, [email protected]


GLOBENEWSWIRE (Distribution ID 9645303)

Namib Minerals Provides Business Update

How Mine Expansion to 55,000 Tonnes Per Month Targeting H2 2026 Operational Date
Enabling Works Commenced at Redwing; 8–Month Dewatering Program to Begin
Company Outlines $300–400 Million Capital Plan with Non–Dilutive Funding Strategy
Management to Host Business Update Conference Call at 8:00 a.m. Eastern Time

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe today provided a business update on its strategic growth initiatives.

“As a publicly traded company, we are committed to transparent communication as we advance our growth strategy,” said Ibrahima Sory Tall, Chief Executive Officer of Namib Minerals. “We are focused on building Namib Minerals into a multi–asset, mid–tier producer through operational optimization at How Mine and the disciplined restart of our Mazowe and Redwing mines. Our engagement of WSP for comprehensive feasibility studies, combined with the commencement of enabling works at Redwing and capacity expansion initiatives at How Mine, demonstrates tangible progress toward our vision. We look forward to updating the investment community on our strategic roadmap and near–term milestones.”

Strategic Growth Update
Since listing on the Nasdaq Stock Exchange in June 2025, Namib Minerals has executed on its strategy to transform from a single–mine operator into a multi–asset gold producer. The Company is advancing a three–pillar growth strategy: operational excellence at How Mine, strategic restarts of Mazowe and Redwing mines, and portfolio diversification through critical minerals exploration.

How Mine Capacity Expansion
As part of its commitment to operational improvement at How Mine, the Company is advancing plans to expand ore milling capacity from 40,500 tonnes per month in 2024 to 55,000 tonnes per month, representing an approximately 36% increase in throughput capacity. The Company is currently working on the procurement of the required equipment and expects this expansion to be operational during the second half of 2026. This capacity expansion will enable the Company to process higher ore volumes and offset the reduction in grade experienced to date in 2025.

Restart Enabling Works
At Redwing, the Company has commenced enabling works. Dewatering is scheduled to commence during the feasibility study phase and is expected to take approximately eight months to reach the targeted mining levels. Dewatering is a critical first step in the restart sequence, allowing the Company to assess underground conditions, refurbish infrastructure, and prepare for a phased production ramp–up. Concurrently, surface–infrastructure and power–supply upgrades will be planned to align with the restart timeline.

At Mazowe, the Company is advancing surface infrastructure work, including power, water, and tailings management systems, alongside detailed engineering studies to optimize the restart sequence and capital efficiency.

WSP Feasibility Studies
Supporting this disciplined approach, the Company has engaged WSP to conduct comprehensive feasibility studies for both Redwing and Mazowe. As announced on November 10, 2025, WSP has been appointed to execute S–K 1300 compliant feasibility studies for both mines simultaneously. Both mines are currently under care and maintenance and require completion of dewatering and resource drilling before redevelopment can commence. The program is expected to be completed over 12 to 18 months and will provide the technical foundation for reserve conversion, permitting, and financing discussions.

Long–Term Strategic Objective
The Company's vision is to build Namib Minerals into a multi–asset, mid–tier gold producer, working toward a strategic goal of ultimately producing 300,000 ounces per year. This represents a long–term corporate objective, not production guidance or a forecast, and is not based on a Preliminary Economic Assessment, Pre–Feasibility Study, or Feasibility Study. Achievement of this objective is contingent upon execution of the Company's long–term strategy, including the successful execution of restart programs and expansion of mines and other exploration and development goals. 

Preliminary Capital Requirements
The Company's preliminary estimate is that the total funding requirement for the expansion program is expected to fall within a range of $300 million to $400 million, with the majority allocated to Redwing Mine. The Company is pursuing a balanced funding mix including structured solutions that minimize dilution and prioritize project debt, strategic partnerships, and internally–generated cash flows to minimize shareholder dilution while supporting growth initiatives. The Company is in dialogue with multiple capital providers to support its growth plans. The Company’s estimated funding requirement amount is preliminary and subject to completion of feasibility studies, final engineering outcomes, market conditions, and equipment costs and other risks and uncertainties, many of which are beyond the Company's control.

Conference Call Information
Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://namibminerals.gcs–web.com/. An archived replay of the webcast will be available on the Company’s website shortly after the event concludes.

Participants may also access the call by dialing (877) 407–9039 for domestic callers or (201) 689–8470 for international callers.

Namib Minerals management will incorporate responses to a selection of shareholders’ frequently asked questions during the webcast. Shareholders are invited to submit questions via the investor relations email address: [email protected]. Please include the hashtag #askNamib in the subject line.

About Namib Minerals
Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Namib Minerals is a significant player in Africa’s mining industry, driving sustainable growth and innovation across the sector. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe. For additional information, please visit namibminerals.com.

Forward–Looking Statements

This press release includes forward–looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts contained in this update are forward–looking statements. Any statements that refer to estimates or other characterizations of future events or circumstances, including any underlying assumptions, are also forward–looking statements. Forward–looking statements include, without limitation, our management teams’ expectations of funding frameworks and anticipated timelines and costs of the restart of the Mazowe and Redwing Mines, and related assumptions. The forward–looking statements are based on our current expectations and are inherently subject to uncertainties and changes in circumstance and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward–looking statements involve a number of risks and uncertainties which include, but are not limited to, (i) market risks, including the price of gold and equipment; (ii) the risk that the Company may not be able to successfully develop its assets as planned, including expanding the How mine and restarting and expanding the Redwing and Mazowe Mines; (iii) the risk that Namib Minerals will be unable to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; and (iv) political and social risks of operating in Zimbabwe and the DRC. The foregoing list is not exhaustive. You should carefully consider the foregoing factors, any other factors discussed in this press release and the other risks and uncertainties described in the filings we make with Securities and Exchange Commission (the “SEC”). We caution you against placing undue reliance on forward–looking statements, which reflect current beliefs and are based on information currently available as of the date a forward–looking statement is made.

Contacts:
Namib Minerals:
Ibrahima Sory Tall
CEO & Director
Investor Relations:
[email protected]


GLOBENEWSWIRE (Distribution ID 9591191)

Namib Minerals Schedules Business Update Call

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African gold producer with a portfolio of mining and exploration assets in Zimbabwe and the Democratic Republic of Congo, today announced that management will host a webcast and conference call to provide a business update at 8:00 AM ET on Monday, November 24, 2025.

Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://namibminerals.gcs–web.com/. An archived replay of the webcast will be available shortly after the event concludes.

Participants may also access the call by dialing (877) 407–9039 for domestic callers or (201) 689–8470 for international callers.

Namib Minerals management will incorporate responses to a selection of shareholders’ frequently asked questions during the webcast. Shareholders are invited to submit questions via the investor relations email address: [email protected]. Please include the hashtag #askNamib in the subject line.

About Namib Minerals

Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Namib Minerals is a significant player in Africa’s mining industry, driving sustainable growth and innovation across the sector. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe, with additional exploration assets in the DRC. For additional information, please visit namibminerals.com.

Contacts:
Namib Minerals:
Ibrahima Sory Tall
CEO & Director
Investor Relations:
[email protected]


GLOBENEWSWIRE (Distribution ID 9580064)

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical–stage biopharmaceutical company developing novel brain–penetrant therapeutics for patients with malignant brain tumors and central nervous system (CNS) disorders, today announced that it will host an investor conference call and webcast on Wednesday, November 12, 2025, at 6:00 a.m. Pacific Time / 9:00 a.m. Eastern Time (prior to market open).

During the call, members of the NTHI management team and independent members of the company’s Scientific Advisory Board (SAB) will present data updates from the Company’s ongoing Phase 1/2a NEO100–1 clinical trial and compassionate use program, evaluating intranasal delivery of NEO100 (high–purity perillyl alcohol) in patients with recurrent high grade malignant glioma.

The discussion will highlight MRI–based radiographic response data, progression–free survival (PFS), and overall survival (OS) trends observed to date, providing important insights into long–term clinical outcomes for patients treated with NEO100.

Featured Participants:

  • Dr. Henry S. Friedman, MD – Deputy Director, Preston Robert Tisch Brain Tumor Center, Duke University; Independent Member, NTHI Scientific Advisory Board
  • Dr. Alexander Miller, MD – Chief Neuro–oncology, Brain Tumor Program, NYU Langone Health; Independent Member, NTHI Scientific Advisory Board
  • NTHI Management Team:
    • Amir Heshmatpour – Chief Executive Officer, Executive Chairman and President
    • Dr. Thomas C. Chen, MD, PhD – Chief Medical Officer and Chief Scientific Officer
    • Dr. Josh Neman, PhD – Chief Clinical Officer
    • Keith Garnett – Chief Financial Officer

Conference Call Details:

  • Date: Wednesday, November 12, 2025
  • Time: 6:00 a.m. PT / 9:00 a.m. ET
  • Webcast: A live webcast can be accessed by visiting https://investors.neonc.com

ABOUT NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings, Inc. is a clinical–stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood–brain barrier. The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s NEO100™ and NEO212™ therapeutics are in Phase II human clinical trials and are advancing under FDA Fast–Track and Investigational New Drug (IND) status. The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.

For more about NeOnc and its pioneering technology, visit neonc.com.

Important Cautions Regarding Forward–Looking Statements
This press release contains “forward–looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward–looking statements can be identified by terminology such as “may,” “will,” “should,” “intend,” “expect,” “plan,” “budget,” “forecast,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “evaluating,” or similar words. Statements that contain these words should be read carefully, as they discuss our future expectations, projections of future results of operations or financial condition, or other forward–looking information.

Examples of forward–looking statements include, among others, statements regarding whether a definitive agreement will be reached with Quazar. These statements reflect our current expectations based on information available at this time, but future events may differ materially from those anticipated.

The “Risk Factors” section of our most recent Annual Report on Form 10–K filed with the Securities and Exchange Commission, along with other cautionary language in that report or in our subsequent filings, outlines important risks and uncertainties. These may cause our actual results to differ materially from the forward–looking statements herein, including but not limited to the failure to finalize the agreement with Quazar, modifications to its terms, or alternative uses of proceeds.

We assume no obligation to revise or update any forward–looking statements, whether as a result of new information, future developments, or otherwise, except as required by applicable securities laws and regulations.

“NEO100” and NEO “212” are registered trademarks of NeOnc Technologies Holdings, Inc.

Company Contact:
[email protected]

Investor Contact:
James Carbonara
Hayden IR
(646)–755–7412
[email protected]


GLOBENEWSWIRE (Distribution ID 9571142)

Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences

  • Osteoporosis Program: Phase 2 analysis exploring the dual actions of oral PTH(1–34) tablet treatment, EB613 on trabecular and cortical bone, and Next–Gen EB613 PK/PD data slated for oral and poster presentations at ASBMR
  • Short Bowel Syndome and Rare GI Disorders: PK/PD of oral GLP–2 tablet candidate poster presentation at ESPEN
  • Corporate Overview at H.C. Wainwright Investor Conference

JERUSALEM, Aug. 28, 2025 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today announced that the Company will present data across three key programs during September 2025. Details on the presentations are available below:

American Society for Bone and Mineral Research (ASBMR) 2025 Annual Meeting:
Oral Presentation – Dr. Rachel B. Wagman

  • Title: Effects of EB613 Tablets [Oral PTH(1–34)] on Trabecular and Cortical Bone Using 3D–DXA: Results from Phase 2 Study (1014)
  • Time: Friday, September 5, 2025, 11:45 AM
  • Location: General Session Room, 6BC (6th Floor, Seattle Convention Center)

EB613 is being developed as the first, once–daily oral anabolic (bone forming) tablet treatment for postmenopausal women with osteoporosis. A placebo–controlled Phase 2 study in 161 post–menopausal women produced a rapid onset of action with increases in BMD at both cortical bone (femoral neck and hip region) and cancellous bone (spine). Based on a July 2025 alignment with FDA, Entera is planning a global Phase 3 registration study of EB613 in women with osteoporosis.

Poster Presentation – Next–Gen EB613

  • Title: Advancing Oral Anabolic Treatments for Osteoporosis: Pre–Clinical Data for Next–Gen EB613 Tablet Utilizing N–Tab™ Proprietary Technology (581)
  • Time: Sunday, September 7, 2025, 2:00 PM – 3:30 PM
  • Location: Discovery Hall, Hall 4B (4th Floor, Seattle Convention Center)

47th European Society for Clinical Nutrition & Metabolism (ESPEN) Congress

Poster Presentation – GLP–2 Short Bowel Syndrome:

  • Title: A First–in–Class Oral GLP–2 Analog for Treatment of Short Bowel Syndrome
  • Time: Saturday, September 13, 2025, 3:30 PM – 4:00 PM
  • Location: Forum Hall Foyer 3, Prague, Czech Republic

The oral GLP–2 tablet program combines a proprietary long acting GLP–2 agonist developed by OPKO Health with Entera's proprietary N–Tab™ technology for patients suffering from short bowel syndrome and additional disorders involving gastrointestinal mucosal inflammation and nutrient malabsorption. Currently, the only approved GLP–2 agonist requires daily subcutaneous injections.

H.C. Wainwright Conference

Entera’s Chief Executive Officer Miranda Toledano will present at the H.C. Wainwright 27th Annual Global Investment Conference. The virtual presentation will be available on Friday, September 5, 2025 at 7:00 AM ET at:

https://journey.ct.events/view/0f59c59b–da4e–4dc2–a865–4f1883eca26f

About Entera Bio

Entera is a clinical stage company focused on developing oral peptide and protein replacement therapies for significant unmet medical needs where an oral tablet form holds the potential to transform the standard of care. The Company leverages on a disruptive and proprietary technology platform (N–Tab™) and a pipeline of first–in–class oral peptide programs targeting PTH(1–34), GLP–1 and GLP–2. The Company’s most advanced product candidate, EB613 (oral PTH(1–34)teriparatide), is being developed as the first oral, osteoanabolic (bone building) once–daily tablet treatment for post–menopausal women with low BMD and high–risk osteoporosis. A placebo controlled, dose ranging Phase 2 study of EB613 tablets (n= 161) met primary (PD/bone turnover biomarker) and secondary endpoints (BMD). Entera is preparing to initiate a Phase 3 registrational study for EB613 with alignment from FDA on the use of BMD as its primary endpoint. The EB612 program is being developed as the first oral PTH(1–34) tablet peptide replacement therapy for hypoparathyroidism. Entera is also developing the first oral oxyntomodulin, a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity; and first oral GLP–2 peptide tablet as an injection–free alternative for patients suffering from rare malabsorption conditions such as short bowel syndrome in collaboration with OPKO Health. For more information on Entera Bio, visit www.enterabio.com or follow us on LinkedIn, Twitter, Facebook, Instagram.

Cautionary Statement Regarding Forward Looking Statements

Various statements in this presentation are “forward–looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements (other than statements of historical facts) in this presentation regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward–looking statements. Words such as, but not limited to, “anticipate,” “believe,” “can,” “could,” “expect,” “estimate,” “design,” “goal,” “intend,” “may,” “might,” “objective,” “plan,” “predict,” “project,” “target,” “likely,” “should,” “will,” and “would,” or the negative of these terms and similar expressions or words, identify forward–looking statements. Forward–looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Forward–looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Important factors that could cause actual results to differ materially from those reflected in Entera’s and OPKO’s forward–looking statements include, among others: changes in the interpretation of clinical data; results of our clinical trials; the FDA’s interpretation and review of our results from and analysis of our clinical trials; unexpected changes in our ongoing and planned preclinical development and clinical trials, the timing of and our ability to make regulatory filings and obtain and maintain regulatory approvals for our product candidates; the potential disruption and delay of manufacturing supply chains; loss of available workforce resources, whether by Entera, OPKO or their respective collaboration and laboratory partners; impacts to research and development or clinical activities that Entera or OPKO may be contractually obligated to provide; overall regulatory timelines; the size and growth of the potential markets for our product candidates; the scope, progress and costs of developing our product candidates; the parties’ reliance on third parties to conduct clinical trials; Entera’s and OPKO’s expectations regarding licensing, business transactions, including OPKO’s development efforts should Entera opt–out, and strategic collaborations; Entera’s operation as a development stage company with limited operating history; Entera’s ability to continue as a going concern absent access to sources of liquidity; Entera’s ability to comply with Nasdaq’s minimum listing standards and other matters related to compliance with the requirements of being a public company in the United States; Entera’s and OPKO’s intellectual property positions and their ability to protect their respective intellectual property; and other factors that are described in the “Cautionary Statements Regarding Forward–Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of each of Entera’s and OPKO’s most recent Annual Reports on Form 10–K filed with the SEC, as well as the companies’ respective subsequently filed Quarterly Reports on Form 10–Q and Current Reports on Form 8–K. There can be no assurance that the actual results or developments anticipated by Entera and OPKO will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Entera or OPKO, as applicable. Therefore, no assurance can be given that the outcomes stated or implied in such forward–looking statements and estimates will be achieved. Entera and OPKO caution investors not to rely on the forward–looking statements made in this press release. The information in this press release is provided only as of the date of this press release, and neither Entera nor OPKO undertakes any obligation to update or revise publicly any forward–looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law.


GLOBENEWSWIRE (Distribution ID 9519749)